This article is more than 5 years old. Information may no longer be current.

Bionect low molecular weight hyaluronic acid made available in foam formula

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Prescription topical Bionect is available in the United States in a foam formula that will hold its shape until application, according to a press release from Cipher Pharmaceuticals.

Bionect Foam features low molecular weight hyaluronic acid and has the moisturizing and healing properties of Bionect cream and gel, according to the release. The non-steroidal foam is well-suited for dressing and managing dermal ulcers, wounds, post-operative incisions, first- and second-degree burns and skin irritations, the release reported.

The foam option allows dermatologists and patients to treat hard-to-reach locations including hair-bearing areas, the release reported.

“Bionect as a foam, coupled with the benefits of low molecular weight hyaluronic acid, gives dermatologists better access to more of the skin’s surface,” Charles F. Jenkins, vice president of marketing, Cipher US, stated in the release.

Reference: www.cipherpharma.com